EP0773034B1 — Biodegradable in-situ forming implants
Assigned to Tolmar Therapeutics Inc · Expires 2002-12-04 · 23y expired
What this patent protects
A biodegradable thermosetting polymer system is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. The thermosetting system comprises mix…
USPTO Abstract
A biodegradable thermosetting polymer system is provided for use in providing syringeable, in-situ forming, solid biodegradable implants for animals. The polymer is placed into the animal in liquid form and cures to form the implant in-situ. The thermosetting system comprises mixing together effective amounts of a liquid acrylic ester terminated, biodegradable prepolymer and a curing agent, placing the liquid mixture within an animal and allowing the prepolymer to cure to form the implant. The system provides a syringeable, solid biodegradable delivery system by the addition of an effective level of biologically active agent to the liquid before injection into the body. <IMAGE> <IMAGE>
Drugs covered by this patent
- Risperdal (risperidone) · Johnson & Johnson (Janssen)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.